Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuVax for Prevention of Recurrence in Early-Stage Breast Cancer
NCT01479244Phase 3Completed
- Sponsor
- Galena Biopharma
- Start
- Nov 2011
- Primary completion
- Sep 2016
- Countries
- 13
01
Overview
A Phase 3 trial of nelipepimut-S in breast cancer, sponsored by Galena Biopharma. Started Nov 2011; status: completed.
02
Drugs
nelipepimut-S
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01479244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479244.